Teratogenic effects of antiepileptic drugs

被引：165

作者：

Tomson, Torbjorn ^{[1
]}

Battino, Dina ^{[2
]}

机构：

[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden

[2] Neurol Inst Carlo Besta Fdn, Epilepsy Ctr, Dept Neurophysiol & Expt Epileptol, IRCCS, Milan, Italy

来源：

LANCET NEUROLOGY | 2012年 / 11卷 / 09期

关键词：

IN-UTERO EXPOSURE; MAJOR CONGENITAL-MALFORMATIONS; CHILDREN BORN; VALPROIC ACID; UK-EPILEPSY; PRELIMINARY EXPERIENCE; PREGNANCY REGISTRIES; SPINA-BIFIDA; WOMEN; FETAL;

D O I：

10.1016/S1474-4422(12)70103-5

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Most women with active epilepsy need treatment with antiepileptic drugs during pregnancy. Antiepileptic drugs are also frequently used for other indications, such as migraine, pain syndromes, and psychiatric disorders, which are prevalent among women of childbearing age. Possible teratogenic effects of antiepileptic drugs are therefore of wide concern and the risks imposed by the drugs must be weighed against the risks associated with the disorder being treated. Adverse drug effects on the fetus can present as fetal loss, intrauterine growth retardation, congenital malformations, impaired postnatal development, and behavioural problems. For optimum use of antiepileptic drugs in women of childbearing age and rational management of epilepsy during pregnancy, a thorough understanding of the teratogenic effects of antiepileptic drugs and knowledge of the differences in risks between various treatment options are needed.

引用

页码：803 / 813

页数：11

共 50 条

[41] The Long-Term Safety of Antiepileptic Drugs
Gaitatzis, Athanasios
Sander, Josemir W.
CNS DRUGS, 2013, 27 (06) : 435 - 455
[42] Effects of the antiepileptic drugs topiramate and lamotrigine on bone metabolism in rats
Kanda, Junkichi
Izumo, Nobuo
Kobayashi, Yoshiko
Onodera, Kenji
Shimakura, Taketoshi
Yamamoto, Noriaki
Takahashi, Hideaki E.
Wakabayashi, Hiroyuki
BIOMEDICAL RESEARCH-TOKYO, 2017, 38 (05): : 297 - 305
[43] TERATOGENIC DETERMINANTS OF FIRST-TRIMESTER EXPOSURE TO ANTIEPILEPTIC MEDICATIONS
Brosh, Koby
Matok, Ilan
Sheiner, Eyal
Koren, Gideon
Wiznitzer, Arnon
Gorodischer, Rafael
Levy, Amalia
JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2011, 18 (01): : E89 - E98
[44] Use of Antiepileptic Medications in Pregnancy in Relation to Risks of Birth Defects
Werler, Martha M.
Ahrens, Katherine A.
Bosco, Jaclyn L. F.
Mitchell, Allen A.
Anderka, Marlene T.
Gilboa, Suzanne M.
Holmes, Lewis B.
ANNALS OF EPIDEMIOLOGY, 2011, 21 (11) : 842 - 850
[45] Are Newer Antiepileptic Drugs Associated with Improved Safety In Pregnancy Compared to Older Antiepileptic Drugs?
Pack, Alison M.
EPILEPSY CURRENTS, 2013, 13 (01) : 15 - U106
[46] Unreported teratogenic effects of anticonvulsants identified
Reactions Weekly, 2001, 836 (1) : 5 - 5
[47] Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects
Jankovic, Slobodan M.
Dostic, Milivoje
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (01) : 81 - 91
[48] Effects of Antiepileptic Drugs on Bone Health and Growth Potential in Children with Epilepsy
Vestergaard, Peter
PEDIATRIC DRUGS, 2015, 17 (02) : 141 - 150
[49] Effects of Antiepileptic Drugs on Lipids, Homocysteine, and C-Reactive Protein
Mintzer, Scott
Skidmore, Christopher T.
Abidin, Caitlin J.
Morales, Megan C.
Chervoneva, Inna
Capuzzi, David M.
Sperling, Michael R.
ANNALS OF NEUROLOGY, 2009, 65 (04) : 448 - 456
[50] Adverse outcomes during pregnancy and major congenital malformations in infants of patients with bipolar and schizoaffective disorders treated with antiepileptic drugs: A systematic review
Gimenez, Anna
Pacchiarotti, Isabella
Gil, Joaquin
Murru, Andrea
Gomes, Susana P.
Pinzon, Justo E.
Anmella, Gerard
Gomez-Ramiro, Marta
Verdolini, Norma
Valenti, Marc
Goikolea, Jose M.
Vieta, Eduard
PSYCHIATRIA POLSKA, 2019, 53 (02) : 223 - 244

← 1 2 3 4 5 →